SEC Form 4 · Rule 10b5-1 trading plans
VERTEX PHARMACEUTICALS INC / MA (VRTX)
- 22Trades filed under a plan
- 0Plan adoption dates stated
- 7Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, VERTEX PHARMACEUTICALS INC / MA filed 22 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 7 reporting owners, covering 22 transactions filed under those plans and 39,411 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 22 names a plan in a footnote. 7 results prints are on file in the same window, which is what makes the interval below measurable.
Trades filed under a plan in VERTEX PHARMACEUTICALS INC / MA 22
- Ambrose Kristen — 2025-02-11 · S · 1,376 shares
- Atkinson Edward Morrow III — 2025-02-11 · S · 1,747 shares
- Biller Jonathan — 2025-02-11 · S · 3,433 shares
- Tatsis Ourania — 2025-02-11 · S · 310 shares
- Ambrose Kristen — 2025-02-18 · S · 671 shares
- Biller Jonathan — 2025-02-18 · S · 1,657 shares
- Tatsis Ourania — 2025-02-18 · S · 244 shares
- ALTSHULER DAVID — 2025-02-20 · S · 1,111 shares
- ALTSHULER DAVID — 2025-02-25 · S · 848 shares
- Ambrose Kristen — 2025-02-25 · S · 884 shares
- Atkinson Edward Morrow III — 2025-02-25 · S · 1,767 shares
- Tatsis Ourania — 2025-02-25 · S · 354 shares
Plan adoption dates stated in VERTEX PHARMACEUTICALS INC / MA 0
Quarterly results prints on file in VERTEX PHARMACEUTICALS INC / MA 7
- 2025-02-10
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-02-12
- 2026-05-04
- 2026-08-03
Trades in the days before a print in VERTEX PHARMACEUTICALS INC / MA 0
- 53 days before the 2025-05-05 print — 2025-03-13 · S · ALTSHULER DAVID · 3,231 shares
- 56 days before the 2025-05-05 print — 2025-03-10 · S · ALTSHULER DAVID · 3,231 shares
- 56 days before the 2025-05-05 print — 2025-03-10 · S · Tatsis Ourania · 3,242 shares
- 56 days before the 2025-05-05 print — 2025-03-10 · S · WAGNER CHARLES F JR · 3,298 shares
- 62 days before the 2025-05-05 print — 2025-03-04 · S · Tatsis Ourania · 4,058 shares
- 63 days before the 2025-05-05 print — 2025-03-03 · S · ALTSHULER DAVID · 3,231 shares
- 67 days before the 2025-05-05 print — 2025-02-27 · S · ALTSHULER DAVID · 1,272 shares
- 67 days before the 2025-05-05 print — 2025-02-27 · S · Atkinson Edward Morrow III · 2,650 shares
- 67 days before the 2025-05-05 print — 2025-02-27 · S · Tatsis Ourania · 530 shares
- 68 days before the 2025-11-03 print — 2025-08-27 · S · Bhatia Sangeeta N. · 266 shares
- 69 days before the 2025-05-05 print — 2025-02-25 · S · ALTSHULER DAVID · 848 shares
- 69 days before the 2025-05-05 print — 2025-02-25 · S · Ambrose Kristen · 884 shares
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- 53Shortest interval, in days
- 0Trades with no later print on file
Reported results dates on file
- 2025-02-10
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-02-12
- 2026-05-04
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 1
- FMC CORP 2
- ELI LILLY & Co 4
- ABEONA THERAPEUTICS INC. 2
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 12
- Lifevantage Corp 1
- IONIS PHARMACEUTICALS INC 29
- ARROWHEAD PHARMACEUTICALS, INC. 9
- GILEAD SCIENCES, INC. 17
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.